Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/27/2025

Management of Gastroenteritis in Pregnant Women

Initial Assessment and Management

  • Pregnant women with severe dehydration should be hospitalized for intravenous fluid replacement and close monitoring, according to the American Gastroenterological Association 1

Diagnostic Evaluation

  • Stool cultures should be obtained for enteroinvasive bacterial infections and Clostridioides difficile testing in pregnant women with gastroenteritis, as recommended by the European Society of Gastrointestinal Endoscopy 2
  • Travel and contact history should be carefully reviewed, with appropriate testing for amoebic or Shigella dysentery in patients with relevant travel history, following guidelines from the European Society of Gastrointestinal Endoscopy 2

Antimicrobial Therapy

  • For pregnant women with Salmonella gastroenteritis, treatment is recommended to prevent extraintestinal spread of the pathogen, according to the Centers for Disease Control and Prevention 3
  • Appropriate antibiotic choices include ampicillin, cefotaxime, ceftriaxone, or TMP-SMZ; fluoroquinolones should be avoided during pregnancy, as advised by the Centers for Disease Control and Prevention 3

Management of Complications

  • Pregnant women hospitalized for gastroenteritis should receive anticoagulant thromboprophylaxis during hospitalization, as recommended by the American College of Gastroenterology 1
  • Outpatients with active inflammatory bowel disease should receive VTE prophylaxis during the third trimester, unless contraindicated, according to the European Society of Gastrointestinal Endoscopy 2

Symptom Management

  • Antiperistaltic drugs are not recommended for pregnant women with diarrhea, as stated by the Centers for Disease Control and Prevention 3

Follow-up and Prevention

  • Household contacts of pregnant women with salmonellosis or shigellosis should be evaluated for asymptomatic carriage to prevent recurrent transmission, as recommended by the Centers for Disease Control and Prevention 3
  • Mental health screening should be performed with appropriate referral to support services, given the increased burden of mental health issues during pregnancy, according to the European Society of Gastrointestinal Endoscopy 2

Pitfalls and Caveats

  • Fluoroquinolones should be avoided during pregnancy due to potential risks to the fetus, as advised by the Centers for Disease Control and Prevention 3
  • Iron tablets should not be used in those with active inflammatory bowel disease as systemic inflammation inhibits absorption, according to the European Society of Gastrointestinal Endoscopy 2
  • Avoid gadolinium as part of MR imaging during pregnancy, as recommended by the European Society of Gastrointestinal Endoscopy 2
  • Do not delay urgent surgery to manage complications solely due to pregnancy, as stated by the American College of Gastroenterology 1

Management of Acute Gastroenteritis in Pregnancy

Initial Assessment

  • Assess hydration status systematically by looking for orthostatic hypotension, decreased skin turgor, dry mucous membranes, and other signs, and obtain accurate body weight and check for adequate bowel sounds before initiating oral therapy, as recommended by the Centers for Disease Control and Prevention (CDC) 4
  • Laboratory studies, such as serum electrolytes, are rarely needed but should be measured when clinical signs suggest abnormal sodium or potassium concentrations, according to the CDC 4

Symptom Management

  • Metoclopramide can be used for nausea and vomiting with less drowsiness, dizziness, and dystonia compared to promethazine, as reported in Gastroenterology 5
  • Ondansetron may enhance compliance with oral rehydration therapy and decrease hospitalization rates, but its use should be considered on a case-by-case basis before 10 weeks of pregnancy due to potential risks, as noted in Gastroenterology 5

Nutritional Support

  • Supplement with vitamin B6 (pyridoxine) for mild cases, as suggested in Gastroenterology 5
  • Give thiamine 100 mg daily for a minimum of 7 days, then 50 mg daily maintenance, to prevent refeeding syndrome and Wernicke encephalopathy until adequate oral intake is established, as recommended in Gastroenterology 5

Critical Pitfalls to Avoid

  • Do not rely on antidiarrheal agents, such as loperamide, as they shift focus away from appropriate fluid and electrolyte therapy and can cause serious side effects, including ileus, as warned by the CDC 4

Treatment of Acute Gastroenteritis in Pregnancy

Initial Management

  • The American Academy of Family Physicians recommends aggressive intravenous hydration for severe dehydration, antimicrobial therapy for bacterial infections, and supportive care with antiemetics, while antiperistaltic agents should be avoided in pregnant women with acute gastroenteritis 6

Antimicrobial Therapy

  • The American Academy of Family Physicians recommends treatment with ampicillin, cefotaxime, ceftriaxone, or trimethoprim-sulfamethoxazole to prevent extraintestinal spread of Salmonella, which can infect the placenta and amniotic fluid, potentially resulting in pregnancy loss 6
  • Fluoroquinolones must be avoided during pregnancy due to potential fetal risks 6

Imaging Considerations

  • The Gut society recommends avoiding gadolinium as part of MR imaging during pregnancy and minimizing radiation exposure with cross-sectional imaging 7

Critical Pitfalls to Avoid

  • The American Academy of Family Physicians advises against using fluoroquinolones during pregnancy due to potential fetal risks 6
  • The Gastroenterology society recommends not withholding necessary interventions solely because the patient is pregnant 8, 9

Management of Diarrhea in Pregnancy

Immediate Assessment and Hydration

  • For mild to moderate dehydration, initiate oral rehydration therapy with small, frequent volumes using oral rehydration salts, as recommended by the Centers for Disease Control and Prevention, to prevent dehydration in pregnant women at 36 weeks gestation 10

Diagnostic Evaluation

  • If diarrhea persists beyond 5 days, high fever is present, or dysentery occurs, consider bacterial pathogens requiring antibiotic treatment, according to the Centers for Disease Control and Prevention, to guide appropriate therapy in pregnant women 10

Symptom Management

  • Ondansetron may enhance compliance with oral rehydration therapy in pregnant women with nausea and vomiting accompanying diarrhea, as reported in Gastroenterology, to improve symptom management 11

Nutritional Support

  • Continue regular diet during diarrhea with foods including starches, cereals, yogurt, fruits, and vegetables, while avoiding foods high in simple sugars and fats, as recommended by the Centers for Disease Control and Prevention, to maintain adequate nutrition in pregnant women at 36 weeks gestation 10

When to Escalate Care

  • Return immediately or call if the patient develops decreased urine output or inability to maintain hydration orally, as recommended by the Centers for Disease Control and Prevention, to prevent severe dehydration in pregnant women at 36 weeks gestation 10
  • Return immediately or call if the patient develops persistent high fever or bloody diarrhea, as recommended by the Centers for Disease Control and Prevention, to guide appropriate therapy in pregnant women 10

Management of Diarrhea in Pregnancy

Diagnostic Evaluation and Antimicrobial Therapy

  • For pregnant women with known inflammatory bowel disease (IBD) and suspected flare, flexible sigmoidoscopy or colonoscopy may be performed if results will affect antenatal management, as recommended by the American Gastroenterological Association 12, 13, 14

Thromboprophylaxis for Hospitalized Patients

  • Pregnant women hospitalized for gastroenteritis or IBD flare should receive anticoagulant thromboprophylaxis during hospitalization, with low-molecular-weight heparin preferred over unfractionated heparin, according to the American College of Gastroenterology 12, 13

Treatment of Diarrhea in Pregnancy

Diagnostic Evaluation and Management

  • For pregnant women with known inflammatory bowel disease and suspected flare, flexible sigmoidoscopy or colonoscopy may be performed if results will affect antenatal management, as recommended by the American Gastroenterological Association 15

Antimicrobial Therapy

  • The Centers for Disease Control and Prevention recommends that pregnant women with confirmed Salmonella gastroenteritis receive mandatory treatment to prevent extraintestinal spread to the placenta and amniotic fluid, which can result in pregnancy loss 16
  • Appropriate antibiotic choices for pregnant women with confirmed Salmonella gastroenteritis include Ampicillin, cefotaxime, ceftriaxone, or trimethoprim-sulfamethoxazole, as recommended by the Centers for Disease Control and Prevention 16
  • Fluoroquinolones must be avoided during pregnancy due to potential fetal risks, as recommended by the Centers for Disease Control and Prevention 16

Prevention of Recurrent Transmission and Critical Pitfalls to Avoid

  • Household contacts of pregnant women with salmonellosis or shigellosis should be evaluated for asymptomatic carriage to prevent recurrent transmission, as recommended by the Centers for Disease Control and Prevention 16
  • The American College of Gastroenterology recommends that anticoagulant thromboprophylaxis be used during hospitalization for gastroenteritis in pregnant women, with low-molecular-weight heparin preferred over unfractionated heparin, and outpatients with active inflammatory bowel disease should receive VTE prophylaxis during the third trimester unless contraindicated 17
  • Avoid gadolinium as part of MR imaging during pregnancy, as recommended by the European Society of Gastrointestinal Endoscopy 17

Management of Diarrhea in Pregnant Women

Inflammatory Bowel Disease Management

  • For pregnant women with ulcerative colitis who have mild to moderate disease flare while on 5-ASA maintenance therapy, the American Gastroenterological Association recommends optimizing combination 5-ASA oral and rectal therapy to induce symptomatic remission 18
  • For pregnant women with IBD who have a disease flare on optimal 5-ASA or thiopurine maintenance therapy, the American Gastroenterological Association suggests treating with systemic corticosteroids or anti-TNF therapy to induce symptomatic remission 18

Guideline Recommendations for Managing Acute Gastroenteritis in Third‑Trimester Pregnancy

Diagnostic Workup

  • Obtain stool cultures for enteroinvasive bacterial pathogens and test for Clostridioides difficile in any pregnant woman presenting with acute gastroenteritis. This helps identify infections that may require targeted therapy and prevents maternal‑fetal complications. 19
  • When a relevant travel or exposure history exists, add stool testing for amoebic dysentery or Shigella species. Tailoring the microbiologic work‑up to epidemiologic risk improves diagnostic yield. 19

Thromboprophylaxis

  • Administer pharmacologic venous thromboembolism (VTE) prophylaxis to all pregnant patients hospitalized for gastroenteritis, using low‑molecular‑weight heparin (LMWH) preferentially over unfractionated heparin. LMWH offers better safety and efficacy in the obstetric population. 19
  • For out‑patient women in the third trimester with active gastroenteritis, initiate VTE prophylaxis unless contraindicated (e.g., active bleeding or heparin allergy). Early prophylaxis reduces the heightened pregnancy‑related risk of thromboembolism. 19

Antimicrobial Therapy

  • Do not prescribe antibiotics for viral gastroenteritis in pregnancy, as they provide no benefit and may cause harm. This aligns with public‑health recommendations to limit unnecessary antimicrobial use. 20

General Management Principles

  • Do not withhold necessary diagnostic or therapeutic interventions solely because the patient is pregnant. Standard care should be provided, with appropriate modifications for fetal safety. 21
  • Avoid the use of gadolinium‑based contrast agents for magnetic resonance imaging in pregnant patients. Gadolinium crosses the placenta and its safety profile in pregnancy is not established. 19

REFERENCES